Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Stress Prevention and Stress Management Techniques I01:26

Stress Prevention and Stress Management Techniques I

Stress prevention and management are crucial for maintaining well-being and building resilience. Techniques to manage stress include cultivating qualities like conscientiousness, a sense of personal control, and self-efficacy. Each of these traits significantly reduces stress and promotes healthier lifestyle choices and outcomes.
Conscientiousness
Conscientious individuals tend to be organized, responsible, and disciplined. They prioritize completing tasks and following structured routines,...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toward Bridging the Gap from Artificial Intelligence in Clinical Research to Clinical Practice in Rheumatology: The Mayo Experience.

Rheumatic diseases clinics of North America·2026
Same author

Efficacy and safety of belimumab and anifrolumab in systemic lupus erythematosus: A systematic review and network meta-analysis.

Seminars in arthritis and rheumatism·2026
Same author

The Association of Osteoarthritis With De Novo Inflammatory Arthritis in Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Study.

Arthritis care & research·2026
Same author

The evolving comorbidity landscape of rheumatoid arthritis.

Nature reviews. Rheumatology·2026
Same author

Deep Learning-Based Comparison of Knee Minimum Joint Space Width in Patients With Rheumatoid Arthritis and Osteoarthritis Before Total Knee Arthroplasty.

The Journal of rheumatology·2026
Same author

Association of Diet, Supplements, and Physical Activity With Risk of Incident Spondyloarthritis.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2026

Related Experiment Video

Updated: Jul 16, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Primer: Demystifying risk--understanding and communicating medical risks.

Cynthia S Crowson1, Terry M Therneau, Eric L Matteson

  • 1Department of Health Sciences Research, all at the Mayo Clinic, Rochester, MN 55905, USA. crowson@mayo.edu

Nature Clinical Practice. Rheumatology
|March 6, 2007
PubMed
Summary

Understanding medical risk measures like absolute risk and relative risk is crucial for evidence-based medicine. Effective communication requires a multifaceted approach addressing patient perception and ensuring informed decision-making.

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Related Experiment Videos

Last Updated: Jul 16, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Area of Science:

  • Medical research
  • Health communication
  • Evidence-based medicine

Background:

  • Accurate comprehension of risk measures is vital for interpreting medical literature and communicating health risks.
  • Complex risk metrics, such as number needed to treat and survival estimates adjusted for competing risks, are frequently misunderstood.
  • Patient perception of risk is influenced by how risks are presented, alongside personal history, cultural factors, and beliefs.

Purpose of the Study:

  • To highlight the importance of understanding various risk measures in evidence-based medicine.
  • To address challenges in communicating complex risk concepts to patients.
  • To advocate for a comprehensive strategy in risk communication.

Main Methods:

  • Discussion of common and complex risk measures (e.g., absolute risk, relative risk, odds ratio, hazard ratio, number needed to treat).
  • Exploration of factors influencing patient perception of risk.
  • Emphasis on a multifaceted communication approach combining qualitative and quantitative assessments.

Main Results:

  • Effective risk communication requires understanding diverse risk measures and patient-specific factors.
  • A patient-centered approach, including understanding their perspective and personalizing decisions, is essential.
  • Addressing the timing and permanence of risks is key for patient comprehension.

Conclusions:

  • A multifaceted approach to risk communication is necessary for patients to understand potential risks.
  • Successful communication involves interactive dialogue to understand patient perspectives and facilitate personalized decision-making.
  • Verifying patient comprehension ensures informed and acceptable medical decisions, especially when facing uncertainty.